Bibliography
- Blume-Peytavi U, Blumeyer A, Tosti A, S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 2011;164(1):5-15
- Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999;341(7):491-7
- McElwee KJ, Shapiro JS. Promising therapies for treating and/or preventing androgenetic alopecia. Skin Therapy Lett 2012;17(6):1-4
- Blumeyer A, Tosti A, Messenger A, Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and men. J Dtsch Dermatol Ges 2011;9(Suppl 6):S1-57
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004;150(2):186-94
- Davies GC, Thornton MJ, Jenner TJ, Novel and established potassium channel openers stimulate hair growth in vitro: implications for their modes of action in hair follicles. J Invest Dermatol 2005;124(4):686-94
- Michelet JF, Commo S, Billoni N, Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. J Invest Dermatol 1997;108(2):205-9
- Kvedar JC, Baden HP, Levine L. Selective inhibition by minoxidil of prostacyclin production by cells in culture. Biochem Pharmacol 1988;37(5):867-74
- Garza LA, Yang CC, Zhao T, Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. J Clin Invest 2011;121(2):613-22
- Mysore V. Finasteride and sexual side effects. Indian Dermatol Online J 2012;3(1):62-5
- Irwig MS. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. J Clin Psychiatry 2012;73(9):1220-3
- Hajheydari Z, Akbari J, Saeedi M, Shokoohi L. Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venereol Leprol 2009;75(1):47-51
- Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil/0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai 2012;95(10):1312-16
- Madheswaran T, Baskaran R, Thapa RK, Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery. AAPS PharmSciTech 2013;14(1):45-52
- Caserini M, Radicioni M, Annoni O, Palmieri R. Pharmacokinetics and pharmacodynamics of finasteride topical solution after single and repeated dose in subjects with androgenetic alopecia. 42nd Annual ESDR Meeting; 18 – 22 September 2012; Venice
- Moftah N, Moftah N, Abd-Elaziz G, Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrastructural evaluation. J Eur Acad Dermatol Venereol 2012; published online 6 April 2012; doi:10.1111/j.1468-3083.2012.04535.x [Epub ahead of print]
- Duque-Estrada B, Vicenzi C, Misciali C, Tosti A. Alopecia secondary to mesotherapy. J Am Acad Dermatol 2009;61(4):707-9
- Kadry R, Hamadah I, Al-Issa A, Multiple scalp abscess with subcutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy. J Drugs Dermatol 2008;7(1):72-3
- Sharma P, Jain D, Maithani M, Development and characterization of dutasteride bearing liposomal systems for topical use. Curr Drug Discov Technol 2011;8(2):136-45
- Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997;124(4):544-7
- Smith S, Fagien S, Whitcup SM, Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study. J Am Acad Dermatol 2012;66(5):801-6
- Sasaki S, Hozumi Y, Kondo S. Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Exp Dermatol 2005;14(5):323-8
- Roenigk HH Jr. New topical agents for hair growth. Clin Dermatol 1988;6(4):119-21
- Available from: www.clinicaltrials.gov/ct2/results?term=androgenetic+alopecia+treatment&Search=Search [Last accessed 24 February 2013]
- Blume-Peytavi U, Lönnfors S, Hillmann K, Garcia Bartels N. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol 2012;66(5):794-800
- Digiuni M, Manni G, Vetrugno M, An evaluation of Therapeutic Noninferiority of 0.005% lanatoprost ophthalmic solution and Xalatan in patients with glaucoma or ocular hypertension. J Glaucoma 2012; [Epub ahead of print]
- Garza LA, Liu Y, Yang Z, Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med 2012;4(126):126ra34
- Colombe L, Michelet JF, Bernard BA. Prostanoid receptors in anagen human hair follicles. Exp Dermatol 2008;17(1):63-72
- Pettipher R, Vinall SL, Xue L, Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. J Pharmacol Exp Ther 2012;340(2):473-82
- Jones RL, Giembycz MA, Woodward DF. Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol 2009;158(1):104-45
- Nelson AM, Loy DE, Lawson JA, Prostaglandin D(2) inhibits wound-induced hair follicle neogenesis through the receptor, Gpr44. J Invest Dermatol 2012; published online 29 November 2012; doi: 10.1038/jid.2012.398 [Epub ahead of print]
- Colombe L, Vindrios A, Michelet JF, Bernard BA. Prostaglandin metabolism in human hair follicle. Exp Dermatol 2007;16(9):762-9
- Blume-Peytavi U, Hillmann K, Dietz E, A randomized, single-blind of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol 2011;65(6):1126-34
- Fu J, Hsu W. Epidermal Wnt controls hair follicle induction by orchestrating dynamic signaling crosstalk between the epidermis and dermis. J Invest Dermatol 2013;13(4):890-98
- Huang S, Zhu X, Liu Y, Wls is expressed in the epidermis and regulates embryonic hair follicle induction in mice. PLoS One 2012;7(9):e45904
- Bielefeld KA, Amini-Nik S, Alman BA. Cutaneous wound healing: recruiting developmental pathways for regeneration. Cell Mol Life Sci 2012; [Epub ahead of print]
- Zhang Y, Tomann P, Andl T, Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction. Dev Cell 2009;17(1):49-61
- Andl T, Reddy ST, Gaddapara T, Millar SE. WNT signals are required for the initiation of hair follicle development. Dev Cell 2002;2(5):643-53
- Ito M, Yang Z, Andl T, Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 2007;447(7142):316-20
- Kishimoto J, Burgeson RE, Morgan BA. Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev 2000;14(10):1181-5
- Millar SE. Molecular mechanisms regulating hair follicle development. J Invest Dermatol 2002;118(2):216-25
- Shimizu H, Morgan BA. Wnt signaling through the [beta]-catenin pathway is sufficient to maintain, but not restore, anagen-phase characteristics of dermal papilla cells. J Investig Dermatol 2004;122(2):239-45
- Chen D, Jarrel A, Guo C, Dermal beta-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation. Development 2012;139(8):1522-33
- Schmidt-Ullrich R, Paus R. Molecular principles of hair follicle induction and morphogenesis. Bioessays 2005;27(3):247-61
- Leirós GJ, Attoresi AI, Balañá ME. Hair follicle stem cell differentiation is inhibited through cross-talk between Wnt/beta-catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia. Br J Dermatol 2012;166(5):1035-42
- Available from: http://www.follicabio.com/content/science-and-technology/ [Last accessed 25 February 2013]
- Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018191-34/DE [Last accessed 25 February 2013]
- Gurvich N, Klein PS. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. Pharmacol Ther 2002;96(1):45-66
- Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 2007;64(16):2090-103
- Lee SH, Yoon J, Shin SH, Valproic acid induces hair regeneration in murine model and activates alkaline phosphatase activity in human dermal papilla cells. PLoS One 2012;7(4):e34152
- Zimber MP, Ziering C, Zeigler F, Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man Phase I clinical trial. J Drugs Dermatol 2011;10(11):1308-12
- Available from: http://www.histogen.com/technology.htm [Last accessed 24 February 2013]
- Cegielski M, Izykowska I, Chmielewska M, Characteristics of MIC-1 antlerogenic stem cells and their effect on hair growth in rabbits. In Vivo 2013;27(1):97-106
- Toyoshima KE, Asakawa K, Ishibashi N, Fully functional hair follicle regeneration through the rearrangement of stem cells and their niches. Nat Commun 2012;3:784
- Available from: http://www.aderansresearch.com/ari_science.html [Last accessed 24 February 2013]
- Available from: http://www.replicel.com/our-science/research-findings/ [Last accessed 24 February 2013]
- Adams JU. Raising hairs. Nat Biotechnol 2011;29(6):474-6
- Available from: http://www.replicel.com/wp-content/uploads/replicelfacts_Dec2012.pdf [Last accessed 24 February 2013]
- Available from: http://www.replicel.com/wp-content/uploads/2012/Phase-I-IIa-Interim-Results.pdf [Last accessed 24 February 2013]
- Eppley BL, Pietzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 2006;118(6):147e-59e
- Li ZJ, Choi HI, Choi DK, Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 2012;38(7 Pt 1):1040-6
- Uebel CO, da Silva JB, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg 2006;118(6):1458-66
- Takikawa M, Nakamura S, Nakamura S, Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg 2011;37(12):1721-9
- Kang JS, Zheng Z, Choi MJ, The effect of CD34+ cell-containing autologous platelet-rich plasma injection on pattern hair loss: a preliminary study. J Eur Acad Dermatol Venereol 2012; published online 20 December 2012; doi:10.1111/jdv.12062 [Epub ahead of print]
- Available from: http://kasiakresearch.com/home.html [Last accessed 24 February 2013]
- Available from: http://www.clinicaltrials.gov/ct2/show/NCT00175617?term=antiandrogens&rank=8 [Last accessed 26 February 2013]
- Trifu V, Tiplica GS, Naumescu E, Cortexolone 17 alpha-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs placebo and tretinoin 0.05% cream. Br J Dermatol 2011;165(1):177-83
- Available from: http://www.clinicaltrials.gov/ct2/show/NCT01631474?term=cortexolone+17a-propionate&rank=1 [Last accessed 26 February 2013]
- Yang CC. Calvitron automated hair transplant system in alopecia treatment: a case report. Kaohsiung J Med Sci 2003;19(9):470-4
- Brandy DA. Conventional grafting combined with minigrafting: a new approach. J Dermatol Surg Oncol 1987;13(1):60-3
- Rassman WR, Bernstein RM, McClellan R, Follicular unit extraction: minimally invasive surgery for hair transplantation. Dermatol Surg 2002;28(8):720-8
- Available from: http://restorationrobotics.com/the-artas-advantage/commitment-to-clinical-excellence/ [Last accessed 24 February 2013]
- Takahashi H, Suzuki Y, Miyauchi Y, Roxithromycin decreases ultraviolet B irradiation-induced reactive oxygen intermediates production and apoptosis of keratinocytes. J Dermatol Sci 2004;34(1):25-33
- Inui S, Nakajima T, Fukuzato Y, Potential anti-androgenic activity of roxithromycin in skin. J Dermatol Sci 2001;27(2):147-51
- Sawaya ME, Keane RW, Blume-Peytavi U, Androgen responsive genes as they affect hair growth. Eur J Dermatol 2001;11(4):304-8
- Trueb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002;37(8-9):981-90
- Whiting DA. Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol 2001;45(3 Suppl):S81-6
- Ito T, Fukamizo H, Ito N, Roxithromycin antagonizes catagen induction in murine and human hair follicles: implication of topical roxithromycin as hair restoration reagent. Arch Dermatol Res 2009;301(5):347-55
- Amor KT, Rashid RM, Mirmirani P. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J 2010;16(2):3
- Haussler MR, Whitfield GK, Haussler CA, The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13(3):325-49
- Reichrath J, Schilli M, Kerber A, Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol 1994;131(4):477-82
- Aoi N, Inoue K, Chikanishi T, 1alpha,25-dihydroxyvitamin D3 modulates the hair-inductive capacity of dermal papilla cells: therapeutic potential for hair regeneration. Stem Cells Transl Med 2012;1(8):615-26
- Yoshizawa T, Handa Y, Uematsu Y, Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997;16(4):391-6
- Vegesna V, O'Kelly J, Uskokovic M, Vitamin D3 analogs stimulate hair growth in nude mice. Endocrinology 2002;143(11):4389-96